Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of the National Cancer Institute|August 18, 2005
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.Nature Clinical Practice. Oncology|September 1, 2005
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.European Journal of Cancer (Oxford, England : 1990)|July 27, 2005
REporting recommendations for tumour MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.Breast Cancer Research and Treatment|August 26, 2006
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.Nature Clinical Practice. Urology|February 17, 2006
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane, Douglas G Altman, Willi Sauerbrei, et al.Clinical Lung Cancer|June 28, 2006
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21Gary M Clark, Denni M Zborowski, Pedro Santabarbara, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinibGary M Clark, Denni M Zborowski, Jennifer L Culbertson, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 4, 2020
Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive marginsPrateek V Jain, Rajeev Sharan, Kapila Manikantan, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 10, 2002
Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assayLynne W Elmore, Heidi L Forsythe, Andrea Ferreira-Gonzalez, et al.Journal of the National Cancer Institute|October 27, 2009
A perspective on challenges and issues in biomarker development and drug and biomarker codevelopmentSheila E Taube, Gary M Clark, Janet E Dancey, et al.Pageof 4